Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
Kirk PS, Zhu K, Zheng Y, Newcomb LF, Schenk JM, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss M, Martin F, McKenney JK, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Gore JL.
Kirk PS, et al. Among authors: nelson ps.
Cancer. 2022 Jan 15;128(2):269-274. doi: 10.1002/cncr.33911. Epub 2021 Sep 13.
Cancer. 2022.
PMID: 34516660
Free PMC article.